Open AccessThe Effectiveness of Hydroxychloroquine Versus Hydroxychloroquine Plus Lopinavir/Ritonavir Therapy in SARS-CoV 2 Pneumonia
Author(s) -
Ayşe Batırel,
Selda Tekin,
Halit Batırel,
Çiğdem Akalan Kuyumcu,
Nurten Bakan
Publication year - 2021
Publication title -
mediterranean journal of infection microbes and antimicrobials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.121
H-Index - 1
ISSN - 2147-673X
DOI - 10.4274/mjima.galenos.2021.2020.8
Subject(s) - medicine , hydroxychloroquine , lopinavir , lopinavir/ritonavir , oxygen therapy , procalcitonin , ritonavir , pneumonia , intensive care unit , retrospective cohort study , hazard ratio , combination therapy , viral load , covid-19 , sepsis , disease , immunology , antiretroviral therapy , human immunodeficiency virus (hiv) , confidence interval , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom